Physician profile
David Lozano
NPI 1104041995
$759.37
in general payments reported to CMS, 2019-2025
17 companies · $86.89 in 2025
The $86.89 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $223 · 2021: $55.74 · 2022: $34.35 · 2023: $31.75 · 2024: $48.56 · 2025: $86.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $167.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $215.45 | 2019-2020 | |
| Amarin Pharma, INC. | $111.20 | 2020-2021 | |
| Novo Nordisk INC | $60.16 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $59.28 | 2019 | |
| Abbvie INC. | $43.16 | 2019-2020 | |
| Glaxosmithkline, LLC. | $40.34 | 2022-2025 | Shingrix |
| Janssen Pharmaceuticals, INC | $31.92 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.75 | 2023 | |
| Hologic Sales and Service, LLC | $25.04 | 2024 | Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $23.31 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $21.63 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $21.44 | 2025 | Jynarque |
| Pfizer INC. | $20.11 | 2025 | |
| Nestle Healthcare Nutrition INC. | $16.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.44 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $11.70 | 2021 | |
| Sanofi-Aventis U.S. LLC | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lozano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.